Next Article in Journal
Bacteriophages and Lysins as Possible Alternatives to Treat Antibiotic-Resistant Urinary Tract Infections
Next Article in Special Issue
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Previous Article in Journal
Biofilm Control Strategies: Engaging with the Public
Previous Article in Special Issue
Antimicrobial Susceptibility and Characterization of Resistance Mechanisms of Corynebacterium urealyticum Clinical Isolates
Communication

Bacteriostatic and Bactericidal Effect of Tigecycline on Leptospira spp.

Department of Veterinary Sciences, University of Pisa, Viale delle Piagge 2, 56124 Pisa, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2020, 9(8), 467; https://doi.org/10.3390/antibiotics9080467
Received: 30 June 2020 / Revised: 28 July 2020 / Accepted: 30 July 2020 / Published: 30 July 2020
Tigecycline is a relatively new antimicrobial, belonging to glycylcyclines with antimicrobial activity against a large spectrum of bacteria. Very few data are available on its effect on Leptospira spp., which consist in a bacteriostatic mechanism. The aim of this investigation was to evaluate the bacteriostatic and bactericidal effect of tigecycline on reference Leptospira strains belonging to 16 serovars. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined through the microdilutions method, and tetracycline was used as the control. Results showed that tigecycline had higher MIC and MBC values than tetracycline. Obtained MIC values were between 4 and 32 µg/mL, while MBC values between 16 and >128 µg/mL. Patoc (MIC: 4 µg/mL; MBC: 16 µg/mL) resulted in the most susceptible serovar, while the most resistant were Bataviae (MIC: 32 µg/mL; MBC: 64 µg/mL), Bratislava (MIC: 8 µg/mL; MBC 128 µg/mL), and Tarassovi (MIC: 8 µg/mL; MBC: >128 µg/mL). This is the first investigation focused on the effect of tigecycline against Leptospira spp. reference strains. Since tigecycline is used as a treatment for bacteremia and urinary tract disease, and these symptoms could be linked to Leptospira infection, the possibility of using this antibiotic as a treatment for leptospirosis should be evaluated. Further studies are needed to explore the possibility to use tigecycline for in vivo application against Leptospira. View Full-Text
Keywords: Leptospira; minimum inhibitory concentration (MIC); microdilutions method; tigecycline; antibiotic susceptibility; leptospirosis Leptospira; minimum inhibitory concentration (MIC); microdilutions method; tigecycline; antibiotic susceptibility; leptospirosis
MDPI and ACS Style

Bertelloni, F.; Cilia, G.; Fratini, F. Bacteriostatic and Bactericidal Effect of Tigecycline on Leptospira spp. Antibiotics 2020, 9, 467. https://doi.org/10.3390/antibiotics9080467

AMA Style

Bertelloni F, Cilia G, Fratini F. Bacteriostatic and Bactericidal Effect of Tigecycline on Leptospira spp. Antibiotics. 2020; 9(8):467. https://doi.org/10.3390/antibiotics9080467

Chicago/Turabian Style

Bertelloni, Fabrizio, Giovanni Cilia, and Filippo Fratini. 2020. "Bacteriostatic and Bactericidal Effect of Tigecycline on Leptospira spp." Antibiotics 9, no. 8: 467. https://doi.org/10.3390/antibiotics9080467

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop